{"indexed":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T13:02:27Z","timestamp":1524488547696},"reference-count":30,"publisher":"Cambridge University Press (CUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec id=\"S0899823X1600115X_abs1\" sec-type=\"objectives\">\n               <jats:title>OBJECTIVES<\/jats:title>\n               <jats:p>To develop common indicators, relevant to both EU member states and the United States, that characterize and allow for meaningful comparison of antimicrobial stewardship programs among different countries and healthcare systems.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec id=\"S0899823X1600115X_abs2\" sec-type=\"general\">\n               <jats:title>DESIGN<\/jats:title>\n               <jats:p>Modified Delphi process.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec id=\"S0899823X1600115X_abs3\" sec-type=\"general\">\n               <jats:title>PARTICIPANTS<\/jats:title>\n               <jats:p>A multinational panel of 20 experts in antimicrobial stewardship.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec id=\"S0899823X1600115X_abs4\" sec-type=\"methods\">\n               <jats:title>METHODS<\/jats:title>\n               <jats:p>Potential indicators were rated on the perceived feasibility to implement and measure each indicator and clinical importance for optimizing appropriate antimicrobial prescribing.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec id=\"S0899823X1600115X_abs5\" sec-type=\"results\">\n               <jats:title>RESULTS<\/jats:title>\n               <jats:p>The outcome was a set of 33 indicators developed to characterize the infrastructure and activities of hospital antimicrobial stewardship programs. Among them 17 indicators were considered essential to characterize an antimicrobial stewardship program and therefore were included in a core set of indicators. The remaining 16 indicators were considered optional indicators and included in a supplemental set.<\/jats:p>\n            <\/jats:sec>\n            <jats:sec id=\"S0899823X1600115X_abs6\" sec-type=\"conclusions\">\n               <jats:title>CONCLUSIONS<\/jats:title>\n               <jats:p>The integration of these indicators in public health surveillance and special studies will lead to a better understanding of best practices in antimicrobial stewardship. Additionally, future studies can explore the association of hospital antimicrobial stewardship programs to antimicrobial use and resistance.<\/jats:p>\n               <jats:p>\n                  <jats:italic>Infect Control Hosp Epidemiol<\/jats:italic> 2016:1\u201311<\/jats:p>\n            <\/jats:sec>","DOI":"10.1017\/ice.2016.115","type":"article-journal","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T10:02:25Z","timestamp":1468576945000},"page":"1201-1211","source":"Crossref","is-referenced-by-count":5,"title":"A Concise Set of Structure and Process Indicators to Assess and Compare Antimicrobial Stewardship Programs Among EU and US Hospitals: Results From a Multinational Expert Panel","prefix":"10.1017","volume":"37","author":[{"given":"Lori A.","family":"Pollack","affiliation":[]},{"given":"Diamantis","family":"Plachouras","affiliation":[]},{"given":"Ronda","family":"Sinkowitz-Cochran","affiliation":[]},{"given":"Heidi","family":"Gruhler","affiliation":[]},{"given":"Dominique L.","family":"Monnet","affiliation":[]},{"given":"J. Todd","family":"Weber","affiliation":[]},{"name":"Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) Expert Panel on Stewardship Structure and Process Indicators","affiliation":[]}],"member":"56","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"key":"S0899823X1600115X_ref1","volume":"4","first-page":"CD003543","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"S0899823X1600115X_ref2","DOI":"10.1093\/jac\/dku046","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref28","volume":"162","first-page":"15","year":"1996","journal-title":"Eur J Surg"},{"key":"S0899823X1600115X_ref27","volume":"17","year":"2012","journal-title":"Euro Surveill"},{"key":"S0899823X1600115X_ref26","DOI":"10.1089\/sur.2008.9951","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref25","DOI":"10.1086\/505220","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref24","DOI":"10.1097\/01.CCM.0000195010.63855.45","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref23","DOI":"10.1186\/1745-6215-15-277","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref22","year":"2001","volume-title":"The RAND\/UCLA Appropriateness Method User\u2019s Manual"},{"key":"S0899823X1600115X_ref21","DOI":"10.1086\/669876","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref20","DOI":"10.1016\/j.clinthera.2013.05.013","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref36","DOI":"10.1093\/heapro\/dai022","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref34","DOI":"10.1002\/j.1875-9114.2012.01163.x","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref33","DOI":"10.1093\/cid\/ciu747","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref30","DOI":"10.1007\/s15010-013-0559-z","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref19","DOI":"10.1086\/670632","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref18","DOI":"10.1086\/665324","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref17","DOI":"10.1093\/jac\/dkq367","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref16","DOI":"10.1007\/s10096-013-1862-4","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref15","DOI":"10.1093\/jac\/dkq456","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref9","DOI":"10.1093\/cid\/cir408","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref8","DOI":"10.1586\/eri.12.140","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref7","DOI":"10.1093\/jac\/dks202","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref6","volume":"63","first-page":"194","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S0899823X1600115X_ref11","volume":"20","first-page":"1","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"S0899823X1600115X_ref5","DOI":"10.1086\/510393","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref10","DOI":"10.1186\/2047-2994-2-31","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref4","DOI":"10.2146\/sp100001","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref3","DOI":"10.1093\/jac\/dkr137","doi-asserted-by":"publisher"},{"key":"S0899823X1600115X_ref29","DOI":"10.1093\/jac\/dks145","doi-asserted-by":"publisher"}],"container-title":"Infection Control & Hospital Epidemiology","original-title":[],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X1600115X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T03:41:04Z","timestamp":1492918864000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":30,"alternative-id":["S0899823X1600115X"],"URL":"http:\/\/dx.doi.org\/10.1017\/ice.2016.115","relation":{"cites":[]},"ISSN":["0899-823X","1559-6834"],"subject":["Microbiology (medical)","Epidemiology","Infectious Diseases"],"container-title-short":"Infect. Control Hosp. Epidemiol."}